Literature DB >> 8261097

Acute and chronic phases of unilateral inflammation in rat's ankle are associated with an increase in the proportion of calcitonin gene-related peptide-immunoreactive dorsal root ganglion cells.

U Hanesch1, U Pfrommer, B D Grubb, H G Schaible.   

Abstract

Using immunocytochemical methods, the proportion of calcitonin gene-related peptide immunoreactive perikarya was determined in dorsal root ganglia L4-L6 in four control rats and in ten rats with a unilateral inflammation in the ankle region of the left hindlimb. The inflammation was induced by subdermal injection of Freund's complete adjuvant at the ankle. Swelling and cellular infiltration of the ankle region developed within 2 days, and were stable and restricted to the injected ankle for the duration of the 3-week study. In control rats approximately 24% of 20,419 perikarya showed calcitonin gene-related peptide (CGRP)-like immunoreactivity. In rats with unilateral inflammation the proportion of CGRP-positive neurons was increased on the inflamed side to approximately 32% of 11,454 cells at day 2 (P < 0.001 with respect to ganglia in normal rats) and approximately 29% of 10,739 perikarya at day 20 post inoculation (P < 0.01). By contrast, no significant changes were found between ganglia in the non-injected side (approximately 25% at day 2 and approximately 24% at day 20). These results demonstrate that peripheral inflammation is associated with an increase in the proportion of neurons in the dorsal root ganglia that synthetize CGRP. This up-regulation is already present at an early stage of inflammation but also at later stages, suggesting that the increased synthesis of CGRP is an important neurobiological reaction associated with the acute and chronic phases of inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261097     DOI: 10.1111/j.1460-9568.1993.tb00481.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

Authors:  Louis P Vera-Portocarrero; Ying Lu; Karin N Westlund
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

2.  Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways.

Authors:  Li-Ya Qiao; John R Grider
Journal:  Exp Neurol       Date:  2009-05-05       Impact factor: 5.330

Review 3.  Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.

Authors:  H Mulder; H Jongsma; Y Zhang; S Gebre-Medhin; F Sundler; N Danielsen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

4.  Loss of neurons in rostral ventromedial medulla that express neurokinin-1 receptors decreases the development of hyperalgesia.

Authors:  S G Khasabov; D A Simone
Journal:  Neuroscience       Date:  2013-07-03       Impact factor: 3.590

5.  Up-regulation of calcitonin gene-related peptide and receptor tyrosine kinase TrkB in rat bladder afferent neurons following TNBS colitis.

Authors:  Li-Ya Qiao; John R Grider
Journal:  Exp Neurol       Date:  2007-01-11       Impact factor: 5.330

6.  Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat.

Authors:  L F Donaldson; D S McQueen; J R Seckl
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

Review 7.  Neuropeptides in gut-brain axis and their influence on host immunity and stress.

Authors:  Pingli Wei; Caitlin Keller; Lingjun Li
Journal:  Comput Struct Biotechnol J       Date:  2020-03-04       Impact factor: 7.271

8.  Interleukin-6-dependent influence of nociceptive sensory neurons on antigen-induced arthritis.

Authors:  Matthias Ebbinghaus; Gisela Segond von Banchet; Julia Massier; Mieczyslaw Gajda; Rolf Bräuer; Michaela Kress; Hans-Georg Schaible
Journal:  Arthritis Res Ther       Date:  2015-11-21       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.